Yochanra (tinengotinib) - Health Xplore

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com

Tag: Yochanra (tinengotinib)

Yochanra Debuts in China as First Drug for FGFR Inhibitor-Resistant Cholangiocarcinoma

News

China Approves TransThera’s Yochanra for FGFR Inhibitor-Resistant Cholangiocarcinoma

The approval makes Yochanra the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma.

imphoenix82
August 7, 2026
0 Comments
88 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email: support@healthxploreindia.com

Contact: +91 9354115542

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: Yochanra (tinengotinib)

China Approves TransThera’s Yochanra for FGFR Inhibitor-Resistant Cholangiocarcinoma

India Amends Medical Devices Rules to Ease Regulatory.

Diabetic Foot Care: Moving Beyond Wound Care

FDA Clears Amygdala Neurosciences’ ANS-858 for Clinical Development

Insurance Coverage for Prostheses Can Empower Amputees, Boost.

About Us

Quick Link

Top Categories

Top Posts

Laser Treatments for Anti-aging: Types, Benefits,

Lilly’s Retatrutide Shows Powerful Weight Loss

National Registry for Implantable Medical Devices: